Bio-IT World Names Keynote Speakers for Upcoming Life Sciences Conference + Expo; Ray Kurzweil, Kari Stefansson, M.D. and Allen Roses, M.D. Address Technology and Research Breakthroughs Impacting Human Health and Drug Discovery
BOSTON, MA – JANUARY 23, 2006 – Bio-IT World, Inc. the leading publisher of information to meet the needs of the biopharma community, today announced that it has named three world-class keynote speakers for its fifth annual conference. The Life Sciences Conference + Expo 2006 (formerly known as the Bio-IT World Conference + Expo) is taking place at the Sheraton Hotel Boston, April 3 through 5, 2006.
The industry luminaries keynoting the conference are Ray Kurzweil, leading inventor and CEO of Kurzweil Technologies; Kari Stefansson, M.D., founder/president/CEO of deCODE genetics; and Allen Roses, M.D., senior vice president of genetics research, GlaxoSmithKline Pharmaceuticals.
Life Sciences Conference + Expo 2006 is the premier event for life science and information technology professionals in pharmaceutical, biotech and academic organizations. It presents the latest technology developments and research breakthroughs on the complete spectrum of topics – from drug discovery to market delivery. Life Sciences Conference + Expo is produced by Bio-IT World in cooperation with the Massachusetts Biotechnology Council (MBC).
"This year's Life Sciences Conference + Expo keynote presenters represent some of the industry's most prominent inventors, entrepreneurs, physicians and scientists," said Bio-IT World editor-in-chief Kevin Davies, Ph.D. "Our keynoters promise to offer illuminating information on the technology and research breakthroughs that are playing a major role in the discovery, development and delivery of critical drugs worldwide."
Ray Kurzweil, Monday, April 3, 2006, 4:00 p.m. – 5:00 p.m.
Ray Kurzweil, founder of research and development giant Kurzweil Technologies, is considered one of the leading inventors of our time. He is the principal developer and inventor of numerous instruments including the first print-to-speech reading tool for the blind; the first CCD flat-bed scanner; the first text-to-speech synthesizer; and the first music synthesizer capable of recreating orchestral instruments. Kurzweil is the recipient of the MIT-Lemelson Prize; and he received the National Medal of Technology, the nation's highest honor in technology. In 2002 he was inducted into the National Inventor's Hall of Fame. He has received 12 honorary Doctorates; honors from three U.S. presidents; and has authored five books. His most recent book is entitled "The Singularity is Near: When Humans Transcend Biology."
Kari Stefansson, MD, Tuesday, April 4, 2006, 8:30 a.m. – 9:30 a.m.
Kari Stefansson, M.D., is the founder, president, CEO and director of deCODE genetics, a global leader in gene discovery, headquartered in Reykjavik, Iceland. Stefansson previously was professor of Neurology, Neuropathology and Neuroscience at Harvard University; and director of Neuropathology at Beth Israel Hospital. He also has held faculty positions in Neurology, Neuropathology and Neurosciences at the University of Chicago. Since launching deCODE ten years ago, Stefansson has built a thriving biopharma company that has not only mapped dozens of major disease genes, but also honed new technologies and strategies to speed the identification of lead compounds, many of which are already entering clinical trials.
Allen Roses, M.D., Wednesday, April 5, 2006, 8:45 a.m. – 9:30 a.m.
Allen Roses, M.D., is senior vice president of Genetics Research at GlaxoSmithKline Pharmaceuticals, where he has organized genetic strategies for susceptibility, gene discovery, pharmacogenetics strategy and implementation; and integration of genetics into medicine discovery and development. Roses was previously the Jefferson Pilot Professor of Neurobiology and Neurology at Duke University. Dr. Roses was one of the first clinical neurologists to apply molecular genetic strategies to neurological diseases. His laboratory at Duke University reported chromosomal location for more than 15 diseases, but is best known for identifying APOE4 as a major, widely confirmed susceptibility gene variant for common late-onset Alzheimer's disease. Roses is a leading authority on the application of pharmacogenomics to the development of personalized medicine. His team applies state-of-the-art genotyping technologies to manage patient populations in clinical trials.
In addition to the keynotes, this year's Life Science Conference + Expo offers conferences and workshops that feature four primary conference tracks, complemented by eight instructional workshops, in which bioscience executives, IT professionals and scientists learn how to utilize technology and informatics to more effectively create, store and analyze data, resulting in accelerated R&D processes and speedier times to market. Major conference tracks include IT/Informatics Solutions for Drug Discovery; E-Clinical Research and Trials; Genomic Medicine and Technology; and the 2006 IDG Venture Summit.
Instructional workshops also will be held during the course of the conference, with titles such as Internet-Based Clinical Trials: Working Together for the Common Good; Emerging Standards for the Semantic Web; Legal Issues for Life Sciences Companies; and Text Mining and its Applications in the Life Sciences.
In conjunction with Bioinformatics.org, Life Sciences Conference + Expo is once again the proud host of the annual Benjamin Franklin Award, a humanitarian award presented for outstanding achievements in open-source bioinformatics.
On the show floor, attendees from all over the world will be able to discover the many new product and service offerings, while interacting with today's top vendors and experiencing hands-on demonstrations.
For complete information or to attend the conference, visit www.lifesciencesexpo.com . Attendees registering on or before February 17, 2006 will receive a discounted registration rate and a free Genography DNA kit. For sponsorship information, contact Dawn Briggs, 203-270-6974.
About Bio-IT World, Inc.
Bio-IT World, Inc. publishes information across a variety of media to meet the needs of bio-IT professionals. Coverage focuses on the application of technology products and services to enable the life sciences R&D value chain in pharmaceutical, biotechnology, healthcare, government and academic research organizations, spanning basic research, drug discovery and development, clinical trials, and regulatory compliance.
The company's premier publication, Bio-IT World and accompanying website, www.bio-itworld.com , deliver the latest news, analysis and information on the indispensable technologies driving innovation in the bio-IT community. Bio-IT World has received more than 34 awards for editorial and design excellence. Established in September 2001, Bio-IT World, Inc., headquartered in Framingham, Mass., is a business unit of International Data Group (IDG), the world's leading technology media, research, and event company.
International Data Group (IDG) is a privately-held company that publishes more than 300 magazines and newspapers including Bio-IT World, CIO, CSO, Computerworld, GamePro, InfoWorld, Network World, and PC World. The company features the largest network of technology-specific Web sites with more than 400 around the world. IDG is also a leading producer of more than 170 computer-related events worldwide including LinuxWorld Conference & Expo(R), Macworld Conference & Expo(R), DEMO(R), and IDC Directions. IDC provides global market research and advice through offices in 50 countries. Company information is available at http://www.idg.com .